Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1016/J.CANEP.2023.102381 | ||||
| Año | 2023 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Within the framework of the Latin America and Caribbean region (LAC) Code Against Cancer 1st edition, the current work presents recommendations to reduce exposure to environmental and occupational carcinogenic agents relevant for LAC. Using the methodology established by the International Agency for Research on Cancer (IARC) in the World Code Against Cancer Framework and experience from developing the European Code Against Cancer 4th edition, a working group of LAC cancer-prevention experts reviewed the list of Group I IARC carcinogenic agents, identified prevalent environmental and occupational exposures in the region, and proposed evidence-based cancer prevention recommendations suited to the epidemiological, socioeconomic, and cultural conditions of LAC countries. Two sets of recommendations were drafted: those targeting the general public and a second set for policymakers. Outdoor and indoor air pollution, ultra-violet radiation and occupational exposures to silica dust, asbestos, benzene, diesel, and welding fumes were identified as prevalent carcinogens in LAC and as agents that could be reduced or eliminated to prevent cancers. Recommendations for additional risk factors were not included due to insufficient data of their attributable burden in LAC (sunbeds, radon, aflatoxin), or lack of a clear preventive action to be taken by the individual (arsenic in drinking water, medical radiation), or lack of evidence of carcinogenicity effect (bisphenol A, phthalates, and pesticides). A broad consensus was reached on environmental and occupational carcinogenic exposures present throughout the LAC region and on individual-level and public policy-level recommendations to reduce or eliminate these exposures. Key educational content for the dissemination of these recommendations was also developed as part of LAC Code Against Cancer 1st Edition.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Blanco, Estela | Mujer |
Universidad Mayor - Chile
Facultad de Medicina - Chile Pontificia Universidad Católica de Chile - Chile |
| 2 | Algranti, Eduardo | - |
FUNDACENTRO - Brasil
|
| 3 | CIFUENTES-LIRA, LUIS ABDON | Hombre |
Pontificia Universidad Católica de Chile - Chile
|
| 4 | López-Carrillo, Lizbeth | - |
Instituto Nacional de Salud Pública. México - México
INST NACL SALUD PUBL - México Instituto Nacional de Salud Pública - México |
| 5 | Mora, Ana M. | Mujer |
University of California, Berkeley - Estados Unidos
UNIV CALIF BERKELEY - Estados Unidos |
| 6 | Rodríguez-Guzmán, Julietta | - |
Universidad El Bosque - Colombia
Univ El Bosque - Colombia |
| 7 | Rodriguez-Villamizar, Laura A. | Mujer |
Universidad Industrial de Santander - Colombia
UNIV IND SANTANDER - Colombia |
| 8 | Veiga, Lene H.S. | - |
National Cancer Institute (NCI) - Estados Unidos
NCI - Estados Unidos |
| 9 | Canelo-Aybar, Carlos | Hombre |
Institut de Recerca Sant Pau (IR SANT PAU) - España
Biomed Res Inst St Pau IIB St Pau - España |
| 10 | Nieto-Gutierrez, Wendy | - |
Institut de Recerca Sant Pau (IR SANT PAU) - España
Biomed Res Inst St Pau IIB St Pau - España |
| 11 | Feliu, Ariadna | Mujer |
Centre international de Recherche sur le Cancer - Francia
Int Agcy Res Canc IARC WHO - Francia |
| 12 | Espina, Carolina | Mujer |
Centre international de Recherche sur le Cancer - Francia
Int Agcy Res Canc IARC WHO - Francia |
| 13 | Ferreccio, Catterina | - |
Facultad de Medicina - Chile
Advanced Center for Chronic Diseases ACCDIS - Chile Pontificia Universidad Católica de Chile - Chile Adv Ctr Chron Dis ACCDiS - Chile |
| Fuente |
|---|
| World Health Organization |
| International Arctic Research Center, University of Alaska, Fairbanks |
| Centre International de Recherche sur le Cancer |
| Latin America |
| Agencia Nacional de Investigación y Desarrollo |
| Sociedade Beneficente Israelita Brasileira Albert Einstein |
| International Agency for Research on Cancer/World Health Organization |
| ANID - MILENIO |
| HIAE |
| Amigos Einstein da Oncologia e Hematologia |
| Sociedade Beneficente Israelita Brasileira Albert Einstein (HIAE) / amigo_h (Amigos Einstein da Oncologia e Hematologia), Brazil |
| International Agency for Research on Cancer (IARC/WHO), France |
| Sociedade Beneficente Israelita Brasileira Albert Einstein (HIAE) / amigo_h (Amigos Einstein da Oncologia e Hematologia), Brazil |
| International Agency for Research on Cancer (IARC/WHO), France |
| Agradecimiento |
|---|
| This article is published as part of a supplement supported by the International Agency for Research on Cancer/World Health Organization. The authors alone are responsible for the views expressed in this article and they do not necessarily represent the views, decisions, or policies of the Institutions with which they are affiliated. |
| This article is published as part of a supplement supported by the International Agency for Research on Cancer/World Health Organization. The authors alone are responsible for the views expressed in this article and they do not necessarily represent the views, decisions, or policies of the Institutions with which they are affiliated. |
| The Latin America and the Caribbean Code Against Cancer project was co-funded by the Sociedade Beneficente Israelita Brasileira Albert Einstein (HIAE) / amigo_h (Amigos Einstein da Oncologia e Hematologia), Brazil (Grant number: DCA-ENV-2020-01) and the International Agency for Research on Cancer (IARC/WHO), France. Estela Blanco acknowledges ANID - MILENIO - NCS2021_013. The systematic reviews have been conducted by the Iberoamerican Cochrane Centre/Biomedical Research Institute Sant Pau (IIB Sant Pau) from Spain. The authors alone are responsible for the views expressed in this manuscript. Where authors are identified as personnel of the International Agency for Research on Cancer/World Health Organization, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy or views of the International Agency for Research on Cancer /World Health Organization. |